<DOC>
	<DOCNO>NCT00421109</DOCNO>
	<brief_summary>The objective study evaluate efficacy tolerability Bilastine 20 mg Q.D. , compare Levocetirizine 5 mg Q.D . placebo treatment Chronic Idiopathic Urticaria .</brief_summary>
	<brief_title>Efficacy Study Symptomatic Treatment Chronic Idiopathic Urticaria</brief_title>
	<detailed_description>A total 540 patient CIU enrol pivotal , randomise , multicentre , international , double-blind , placebo active-comparator control , parallel study . Patients select public private clinical practice . The study population include male females 18 70 year age , suffer CIU least 6 week prior entry study identifiable cause .</detailed_description>
	<mesh_term>Urticaria</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>18 70 year old . Documented history CIU least 6 week prior entry study . Dermatological pathology chronic idiopathic urticaria . History autoimmune disorder , Hodgkin 's disease , lymphoma , leukemia generalize cancer . Pregnant breastfeed woman . Patients operate heavy machinery need drive motor vehicle essential part profession . Patients recent history ( within previous 12 month ) drug addiction alcohol abuse . Patients currently participate participate another clinical trial within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Urticaria</keyword>
	<keyword>Hives</keyword>
	<keyword>Wheals</keyword>
	<keyword>Flare</keyword>
	<keyword>Chronic</keyword>
	<keyword>Idiopathic</keyword>
	<keyword>Erythema</keyword>
	<keyword>Skin disease , vascular</keyword>
	<keyword>Hypersensitivity , Immediate</keyword>
	<keyword>Allergic</keyword>
	<keyword>Cutaneous</keyword>
</DOC>